ClinicalTrials.gov
ClinicalTrials.gov Menu

Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03190915
Recruitment Status : Recruiting
First Posted : June 19, 2017
Last Update Posted : August 15, 2018
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 30, 2020
  Estimated Study Completion Date : December 30, 2020